Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the rat
- 1 March 2000
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 78 (4) , 329-338
- https://doi.org/10.1139/y99-133
Abstract
Doxorubicin treatment causes delayed development of cardiotoxicity. Whether the doxorubicin-induced impairment of cardiac functions reverses or progresses with time after the cessation of the treatment was examined. The rats were injected with doxorubicin (2.5 mg/kg, i.v., once a week for 3 weeks) and sacrificed at 1 (1W), 13 (13W), or 18 (18W) weeks after the final doxorubicin administration. The time to peak of twitch contraction observed at 2-Hz stimulation was not altered in left atrial or ventricular muscle preparations isolated from 1W rats, but it was prolonged in those from 13W and 18W rats. The reduction of the magnitude of postrest contraction and the alteration of force-frequency relationships in left atrial muscle preparations in 1W rats were not significant, but were intensified in the 13W and 18W groups. Alterations in the postrest contraction and the force-frequency relationships in ventricular muscle preparations isolated from doxorubicin-treated rat hearts were weaker, but the pattern of alteration was similar to that observed in left atrial muscle preparations. Caffeine-induced contraction observed in skinned fibers that were isolated from the 1W rats was not altered, but it was reduced in the 18W rats. The Ca2+ sensitivity of contractile proteins was not altered in doxorubicin-treated rat hearts in any of the groups. The Kd values estimated from a [3H]ryanodine binding study were not altered, but the Bmax values were significantly lower in the 13W and 18W groups than those observed in control rats. These results suggest that the dysfunction of the sarcoplasmic reticulum progresses after the completion of doxorubicin treatment and contributes to the doxorubicin-induced late cardiotoxicity.Key words: doxorubicin, late cardiotoxicity, rat heart, sarcoplasmic reticulum.Keywords
This publication has 26 references indexed in Scilit:
- Contractile Failure in Chronic Doxorubicin-induced CardiomyopathyJournal of Molecular and Cellular Cardiology, 1997
- Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.Journal of Clinical Investigation, 1993
- On the Mechanism by Which Doxorubicin Abolishes the Oscillatory Events Induced by Ca Overload in Single Cardiac MyocytesJournal of Cardiovascular Pharmacology, 1991
- Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in ChildhoodNew England Journal of Medicine, 1991
- Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum.Circulation Research, 1990
- Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancerThe Journal of Pediatrics, 1990
- Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesiclesJournal of Molecular and Cellular Cardiology, 1989
- Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and reviewThe American Journal of Medicine, 1986
- P1,P5-Di(Adenosine-5′)Pentaphosphate(Ap5A) as an Inhibitor of Adenylate Kinase in Studies of Fragmented Sarcoplasmic Reticulum from Bullfrog Skeletal Muscle1The Journal of Biochemistry, 1980
- Inotropic and electrophysiological actions of verapamil and D600 in mammalian myocardiumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1975